Forty patients with chronic sinusitis
were recruited for this study, which compared saline (salt water) solution, the preferred method of cleansing the sinuses for many ear, nose, and throat (ENT) doctors, to the antimicrobial sinus solution.
The diagnosis of chronic sinusitis
was made with two major criteria--nasal discharge, post nasal drip and one minor criterion--headache the diagnosis was confirmed by X-ray PNS (Water's view).
Allergies and infections contribute to chronic sinusitis
by keeping the sinus membranes inflamed.
On the opening day of the 10th Middle East Update in Otolaryngology Conference and Exhibition, specialists in the Ear, Nose and Throat (ENT) field said surgery is a solution for those suffering from chronic sinusitis
Our goal is to improve the quality of life for millions of chronic sinusitis
Though the sinuses' underlying purpose is still unclear, they are all too familiar to American doctors and their patients because of what happens when the thin tissues lining them become inflamed, as occurs in chronic sinusitis
We selected the novel secretory PLUNC protein for immunohistochemical analysis in paraffin-embedded tissue samples to validate the differential expression among nasal polyps, chronic sinusitis
, and normal nasal mucosal tissue, and to observe the localization of its expression in tissues and cells.
Out of 48 patients, x ray PNS showed chronic sinusitis
in 26 (54%) patients and 22 patients were having normal x ray PNS.
Despite the fact that chronic sinusitis
is by far the most common chronic respiratory disease, with a market twice the size of asthma, there is currently no approved prescription pharmaceutical for the condition.
Since many patients, such as chronic sinusitis
sufferers or patients that experience reoccurring sinus infections, feel that current therapies are expensive, ineffective, or painful, new therapy options are needed for the more than 35 million sufferers in the U.
has signed an amendment to its exclusive option agreement with the Mayo Foundation for Medical Research and Education (Mayo Clinic) to license any and all intranasal antifungals for chronic sinusitis
Accentia proposes to move forward with its first phase 3 study on recurrent post-surgical chronic sinusitis
patients, and would like to include in its confirmatory phase 3 study additional patients who suffer from moderate to severe chronic sinusitis
but have not had surgery, in order to seek an expanded label indication when the drug launches.